Fundraising Fox
Clearmind Medicine
NASDAQ: CMNDVancouver · Founded 2021 · Canada (Federal Level) corporation · 7 employees on LinkedIn · 1 known investors
Find your way into Clearmind Medicine
Each arrow is one introduction. Sign up to fill in the first one.
201 people can intro you to Adi
Ask Eric So to introduce you to Adi Zuloff-Shani
You →Eric · together at Therapix Biosciences Ltd. →Adi
Sign up to find every way you can get introduced to Clearmind Medicine
- Your email: who you already know at Clearmind Medicine, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Clearmind Medicine team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Clearmind Medicine is a clinical-stage biotech developing proprietary psychedelic-based treatments, with a focus on alcohol use disorder and related conditions. Its therapies are designed to be self-administered, and the company is publicly listed on the Nasdaq (CMND) and Frankfurt Stock Exchange (CWY0).
Founders & leadership
AR
Alan RootenbergExecutive
AZ
Adi Zuloff-ShaniCEODr. Adi Zuloff-Shani holds a Ph.D. from Bar-Ilan University and has spent more than two decades in biomedical research and therapeutics development, including over seven years leading R&D at Macrocure; she is CEO of Clearmind Medicine, a Nasdaq-listed clinical-stage biotech developing non-hallucinogenic psychedelic-based treatments for conditions including alcohol use disorder.
Board
YS
Yehonatan ShacharBoard director
AI
Asaf ItzhaikBoard director
AW
Amitay WeissBoard director
OA
Oz AdlerBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$2.4M disclosed across 1 round · 2024
▶$2.4MraisedFeb 2024 · 12 investors · BiotechnologyRule 506(b)
▶$2.4MraisedFeb 2024 · 12 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Yehonatan ShacharDirector
- Asaf ItzhaikDirector
- Dr. Adi Zuloff-ShaniExecutive Officer
- Amitay WeissDirector
- Alan RootenbergExecutive Officer
- Oz AdlerDirector
- Prof. Mark HadenExecutive Officer
- Offering amount
- $2.4M
- Amount sold
- $2.4M
- Sales commissions
- $192K
- Placement agents
- Aegis Capital Corp.
- First sale
- Jan 2024
- Incorporated
- Corporation, Canada (federal Level)
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 5
NasdaqNasdaq operates a technology infrastructure platform for financial markets across three business segments: Capital Access Platforms (which includes listing services, indices, and analytics tools), Financial Technology (comprising compliance, regulatory, and capital markets software), and Market Services (equities and derivatives trading operations). The company serves financial institutions, listed companies, investment managers, and regulatory agencies globally.
RobinhoodRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
Seeking AlphaSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
StockTwitsStocktwits operates an online community platform where investors and traders share ideas, analysis, and trade discussions organized around stock tickers. The page presented is its community guidelines rather than a product description.
Simply Wall StSimply Wall St is an investment platform that provides financial data visualization and analysis tools for individual investors. The platform serves long-term investors globally by simplifying complex market information into visual and narrative formats to make stock investing more accessible.
Companies working in the same space as Clearmind Medicine.
Frequently asked questions
- What does Clearmind Medicine do?
- Clearmind Medicine is a clinical-stage biotech developing proprietary psychedelic-based treatments, with a focus on alcohol use disorder and related conditions. Its therapies are designed to be self-administered, and the company is publicly listed on the Nasdaq (CMND) and Frankfurt Stock Exchange (CWY0).
- Who are Clearmind Medicine's investors?
- Clearmind Medicine's investors include Khosla Ventures.
- How much funding has Clearmind Medicine raised?
- Clearmind Medicine has disclosed $2.4M raised across 1 round.
- Where is Clearmind Medicine headquartered?
- Clearmind Medicine is headquartered in Vancouver.